搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
20 小时
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
FierceBiotech
3 天
Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...
9 天
Consider Buying Gilead To Benefit From Its Strong Outlook, Favorable Valuation
Discover why Gilead Sciences is a strong buy with potential blockbuster drugs in HIV and oncology, favorable valuation, and a ...
bovnews
15 小时
The Gilead Sciences, Inc. Rollercoaster: What’s Behind the Latest GILD Stock Fluctuation?
On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...
12 天
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...
FiercePharma
12 天
Gilead strikes licensing deals with 6 generics makers to boost access to long-acting HIV ...
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV ...
3 天
Gilead's HIV Prevention Treatment Lenacapavir Shows Potential
GILD's recent upbeat data on lenacapavir underscore the investigational drug???s potential to prevent HIV in the targeted ...
12 天
Gilead strikes deal to rush HIV prevention drug to countries most in need
Why Gilead cut a deal with 6 generics companies around a yet-to-be-approved, twice-a-year HIV PrEP drug: "It really is all ...
12 天
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...
12 天
Gilead licenses HIV-prevention drug to generic drugmakers
US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell ...
CSR Wire
5 天
Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV ...
Despite major advances in scientific innovation, access to care and growth of health systems, there are still millions of ...
11 天
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a two-day winning streak.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈